p53 in drug resistance in ovarian cancer
- 1 May 1997
- journal article
- Published by Elsevier in The Lancet
- Vol. 349 (9064), 1556
- https://doi.org/10.1016/s0140-6736(05)62140-x
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Role of p53 in drug resistance in ovarian cancerThe Lancet, 1997
- p53 activity and chemotherapyNature Medicine, 1996
- Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosisNature Medicine, 1996